HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

3D MEDICINES

4.110

-0.040-0.96%

Volume:18.50K

Turnover:77.15K

Market Cap:1.06B

PE:-5.51

High:4.210

Open:4.160

Low:4.040

Close:4.150

52wk High:10.020

52wk Low:2.830

Shares:258.00M

HK Float Shares:258.00M

Volume Ratio:0.12

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.746

ROE:-25.33%

ROA:-5.25%

PB:1.31

PE(LYR):-5.51

PS:2.08

Loading ...

Overview Company News Filings

3D Medicines (01244): Board Meeting Set for 31 March 2026 to Approve FY 2025 Audited Results and Consider Final Dividend

Bulletin Express

3D Medicines sets board meeting to approve audited annual results and consider final dividend

3D Medicines (01244) Announces February 2026 Monthly Return with No Change in Share Capital

Bulletin Express

BRIEF-3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA

3D MEDICINES Receives NMPA Acceptance for Full Approval Application of Envida®

3D Medicines Inc. (Stock Code: 1244) Announces NMPA Acceptance for Envafolimab Conditional-to-Regular Approval Application

Bulletin Express

3D Medicines Inc - Envafolimab Supplemental Application for Conditional-to-Regular Approval Transition Accepted by Nmpa

THOMSON REUTERS

BRIEF-3D Medicines Inc Says Zhang Jing Resigns As CFO

3D MEDICINES (01244) Appoints Lu Xiao Hao as Chief Financial Officer

3D Medicines Inc. Appoints Lu Xiaohao as Chief Financial Officer

3D Medicines Inc - Zhang Jing Resigns as CFO

THOMSON REUTERS

BRIEF-3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted

3D MEDICINES (01244): New Drug Application for ENVAFOLIMAB as First-Line Treatment for Biliary Tract Cancer Accepted by NMPA

3D Medicines Inc - New Drug Application for First-Line Treatment of Biliary Tract Cancer of Envafolimab Accepted by Nmpa

THOMSON REUTERS

BRIEF-3D Medicines Says Envafoimab Granted Orphan Drug Designation

3D MEDICINES (01244): ENVAFOLIMAB® Granted Orphan Drug Designation for Gastric and Gastroesophageal Junction Cancer

3D Medicines Inc - Envafoimab Granted Orphan Drug Designation

THOMSON REUTERS

3D Medicines Inc - Designation for Treatment of Gastric Cancer and - Gastro-Esophageal Junction Cancer Indications by China Nmpa

THOMSON REUTERS

3D Medicines Inc. (01244) Publishes November 2025 Monthly Return on Movements in Share Capital

Bulletin Express

Does 3D Medicines (HKG:1244) Have A Healthy Balance Sheet?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01244/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01244","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01244\",,,,,undefined,":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"3D MEDICINES","latestPrice":4.11,"timestamp":1773994127094,"preClose":4.15,"halted":0,"volume":18500,"delay":0,"changeRate":-0.009638554216867478,"floatShares":258000000,"shares":258000000,"eps":-0.745688,"marketStatus":"Market Closed","change":-0.04,"latestTime":"03-20 16:08:47","open":4.16,"high":4.21,"low":4.04,"amount":77150,"amplitude":0.040964,"askPrice":4.29,"askSize":110000,"bidPrice":4.11,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":-0.716,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":7,"adr":0,"listingDate":1671033600000,"exchange":"SEHK","adjPreClose":4.15,"openAndCloseTimeList":[[1773970200000,1773979200000],[1773982800000,1773993600000]],"volumeRatio":0.11662064876698174,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01244\",,,,,undefined,":{"symbol":"01244","floatShares":258000000,"roa":"-5.25%","roe":"-25.33%","lyrEps":-0.745688,"volumeRatio":0.11662064876698174,"shares":258000000,"dividePrice":0,"high":4.21,"amplitude":0.040964,"preClose":4.15,"low":4.04,"week52Low":2.83,"pbRate":"1.31","psRate":"2.08","week52High":10.02,"institutionHeld":0,"latestPrice":4.11,"committee":-0.864407,"eps":-0.745688,"divideRate":0,"volume":18500,"delay":0,"ttmEps":-0.716,"open":4.16,"prevYearClose":5.33,"prevWeekClose":3.88,"prevMonthClose":4.22,"prevQuarterClose":5.33,"fiveDayClose":3.88,"twentyDayClose":3.88,"sixtyDayClose":5.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01244\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"01244","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null},{"date":"2025-03-31","symbol":"01244","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"","dateTimestamp":1743350400000,"actualEps":null},{"date":"2024-08-30","symbol":"01244","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-28","symbol":"01244","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null},{"date":"2023-08-25","symbol":"01244","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692927000000,"name":null,"time":"","dateTimestamp":1692892800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01244\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01244\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01244\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01244","date":"2026-03-20","current":-5.740223,"percent":0.427136,"low":-28.336282,"twenty":-9.723168,"median":-4.649929,"eighty":-1.50404,"high":-0.81646,"avg":-5.859544,"sd":5.499382,"marketCap":1008533139},"quantilePoints":[{"date":"2022-12-16","current":-5.235581,"twenty":-5.194732,"median":-5.133459,"eighty":-5.072186,"marketCap":8372275500},{"date":"2022-12-23","current":-6.751983,"twenty":-6.543983,"median":-5.235581,"eighty":-5.077534,"marketCap":10813656600},{"date":"2022-12-30","current":-6.767319,"twenty":-6.712359,"median":-6.402376,"eighty":-5.148831,"marketCap":10864785000},{"date":"2023-01-06","current":-6.226972,"twenty":-6.656867,"median":-6.222642,"eighty":-5.210387,"marketCap":10136205300},{"date":"2023-01-13","current":-7.37795,"twenty":-6.732171,"median":-6.222641,"eighty":-5.594946,"marketCap":12265130300},{"date":"2023-01-20","current":-8.341784,"twenty":-7.927956,"median":-6.590746,"eighty":-6.153938,"marketCap":13827078000},{"date":"2023-01-27","current":-8.887181,"twenty":-8.29701,"median":-6.626477,"eighty":-6.173882,"marketCap":14710474650},{"date":"2023-02-03","current":-9.818889,"twenty":-8.561628,"median":-6.759651,"eighty":-6.207684,"marketCap":16413253700},{"date":"2023-02-10","current":-10.950171,"twenty":-9.057248,"median":-7.285533,"eighty":-6.21386,"marketCap":18180047000},{"date":"2023-02-17","current":-11.265498,"twenty":-10.887738,"median":-8.294627,"eighty":-6.216589,"marketCap":18487315400},{"date":"2023-02-24","current":-11.945022,"twenty":-11.14549,"median":-8.423763,"eighty":-6.223508,"marketCap":19460332000},{"date":"2023-03-03","current":-11.784199,"twenty":-11.481722,"median":-8.611211,"eighty":-6.268952,"marketCap":19191472150},{"date":"2023-03-09","current":-11.61047,"twenty":-11.80525,"median":-11.61047,"eighty":-11.495733,"marketCap":18768978100},{"date":"2023-03-17","current":-10.510874,"twenty":-11.61047,"median":-9.19385,"eighty":-6.590746,"marketCap":17155819000},{"date":"2023-03-24","current":-10.701763,"twenty":-11.419242,"median":-10.069416,"eighty":-6.626477,"marketCap":17667933000},{"date":"2023-03-31","current":-15.732359,"twenty":-11.419242,"median":-10.480963,"eighty":-6.702453,"marketCap":18410498300},{"date":"2023-04-06","current":-15.31556,"twenty":-11.629854,"median":-10.59211,"eighty":-6.732171,"marketCap":17911187150},{"date":"2023-04-14","current":-16.033212,"twenty":-11.88583,"median":-10.670743,"eighty":-6.758117,"marketCap":18768978100},{"date":"2023-04-21","current":-15.395865,"twenty":-12.066551,"median":-10.714024,"eighty":-6.937638,"marketCap":18013609950},{"date":"2023-04-28","current":-15.390094,"twenty":-14.829901,"median":-10.815396,"eighty":-7.26705,"marketCap":17872778600},{"date":"2023-05-05","current":-15.14477,"twenty":-15.096291,"median":-10.950171,"eighty":-7.558484,"marketCap":17616721600},{"date":"2023-05-12","current":-14.695647,"twenty":-15.016098,"median":-11.115161,"eighty":-8.283421,"marketCap":16976579100},{"date":"2023-05-19","current":-15.568444,"twenty":-15.161816,"median":-11.232374,"eighty":-8.29701,"marketCap":17731947250},{"date":"2023-05-25","current":-18.511008,"twenty":-15.297504,"median":-11.265498,"eighty":-8.306544,"marketCap":20996674000},{"date":"2023-06-02","current":-18.698574,"twenty":-15.395865,"median":-11.514856,"eighty":-8.341784,"marketCap":21137505350},{"date":"2023-06-09","current":-20.619698,"twenty":-15.557234,"median":-11.635826,"eighty":-8.505742,"marketCap":23275581300},{"date":"2023-06-16","current":-24.684923,"twenty":-15.691183,"median":-11.873919,"eighty":-8.528573,"marketCap":27730973100},{"date":"2023-06-23","current":-24.705709,"twenty":-16.090083,"median":-11.940062,"eighty":-8.660795,"marketCap":27602944600},{"date":"2023-06-30","current":-22.364101,"twenty":-16.915099,"median":-12.111765,"eighty":-8.848515,"marketCap":24760711900},{"date":"2023-07-07","current":-25.814172,"twenty":-17.959984,"median":-12.75237,"eighty":-8.980102,"marketCap":28524749800},{"date":"2023-07-14","current":-27.330801,"twenty":-18.712777,"median":-13.98411,"eighty":-9.111165,"marketCap":30624417200},{"date":"2023-07-21","current":-12.007318,"twenty":-19.549016,"median":-14.162555,"eighty":-9.227287,"marketCap":13391781100},{"date":"2023-07-28","current":-11.008658,"twenty":-18.871941,"median":-13.41318,"eighty":-9.705027,"marketCap":12264832500},{"date":"2023-08-04","current":-9.833505,"twenty":-18.712777,"median":-12.415562,"eighty":-9.830582,"marketCap":10973797500},{"date":"2023-08-11","current":-8.679354,"twenty":-18.606572,"median":-12.111765,"eighty":-9.249536,"marketCap":9631121100},{"date":"2023-08-18","current":-6.318827,"twenty":-18.525521,"median":-11.971877,"eighty":-8.885914,"marketCap":6961539797},{"date":"2023-08-25","current":-6.432387,"twenty":-18.368074,"median":-11.933477,"eighty":-8.524007,"marketCap":6190554934},{"date":"2023-09-01","current":-6.194611,"twenty":-17.959984,"median":-11.711151,"eighty":-8.293334,"marketCap":5986470705},{"date":"2023-09-08","current":-6.577078,"twenty":-17.736045,"median":-11.625872,"eighty":-7.868908,"marketCap":6281259035},{"date":"2023-09-15","current":-6.773867,"twenty":-17.303542,"median":-11.399359,"eighty":-6.948655,"marketCap":6519357302},{"date":"2023-09-22","current":-5.241742,"twenty":-17.015751,"median":-11.265498,"eighty":-6.764252,"marketCap":5022739626},{"date":"2023-09-29","current":-3.231794,"twenty":-16.915099,"median":-11.197628,"eighty":-6.596683,"marketCap":3102080274},{"date":"2023-10-06","current":-1.966478,"twenty":-16.894694,"median":-11.115161,"eighty":-6.54911,"marketCap":1886645313},{"date":"2023-10-13","current":-2.556458,"twenty":-16.610468,"median":-11.0629,"eighty":-6.365745,"marketCap":2449010743},{"date":"2023-10-20","current":-2.036469,"twenty":-16.360175,"median":-10.91912,"eighty":-6.230191,"marketCap":1947870581},{"date":"2023-10-27","current":-1.892665,"twenty":-16.203825,"median":-10.830756,"eighty":-6.215728,"marketCap":1809546826},{"date":"2023-11-03","current":-2.282688,"twenty":-15.91829,"median":-10.726285,"eighty":-6.191906,"marketCap":2188236451},{"date":"2023-11-10","current":-1.930635,"twenty":-15.740488,"median":-10.676359,"eighty":-6.122365,"marketCap":1850363672},{"date":"2023-11-17","current":-1.993103,"twenty":-15.715889,"median":-10.643018,"eighty":-5.771435,"marketCap":1927462159},{"date":"2023-11-24","current":-2.118695,"twenty":-15.678831,"median":-10.480963,"eighty":-5.19779,"marketCap":2065785913},{"date":"2023-12-01","current":-2.049728,"twenty":-15.641544,"median":-10.295053,"eighty":-4.607854,"marketCap":2006828247},{"date":"2023-12-08","current":-1.976655,"twenty":-15.595422,"median":-9.845074,"eighty":-2.945248,"marketCap":1927462159},{"date":"2023-12-15","current":-1.907502,"twenty":-15.56396,"median":-9.650203,"eighty":-2.555641,"marketCap":1870772095},{"date":"2023-12-22","current":-1.688979,"twenty":-15.553828,"median":-9.249472,"eighty":-2.396938,"marketCap":1655349854},{"date":"2023-12-29","current":-1.758268,"twenty":-15.54872,"median":-9.138123,"eighty":-2.341916,"marketCap":1732448340},{"date":"2024-01-05","current":-1.682682,"twenty":-15.54659,"median":-8.887181,"eighty":-2.243319,"marketCap":1646279444},{"date":"2024-01-12","current":-1.517315,"twenty":-15.468951,"median":-8.686602,"eighty":-2.113759,"marketCap":1485279663},{"date":"2024-01-19","current":-1.340785,"twenty":-15.406627,"median":-8.505742,"eighty":-2.07519,"marketCap":1310674268},{"date":"2024-01-26","current":-1.457805,"twenty":-15.391248,"median":-8.300586,"eighty":-2.05018,"marketCap":1419519190},{"date":"2024-02-02","current":-1.322034,"twenty":-15.330467,"median":-8.28062,"eighty":-2.023434,"marketCap":1285673940},{"date":"2024-02-09","current":-1.385162,"twenty":-15.30841,"median":-7.807137,"eighty":-1.99282,"marketCap":1353699016},{"date":"2024-02-16","current":-1.414894,"twenty":-15.302975,"median":-7.37795,"eighty":-1.982259,"marketCap":1383054549},{"date":"2024-02-23","current":-1.478355,"twenty":-15.281623,"median":-6.937014,"eighty":-1.962187,"marketCap":1437469810},{"date":"2024-03-01","current":-1.591621,"twenty":-15.225796,"median":-6.773867,"eighty":-1.916755,"marketCap":1548567634},{"date":"2024-03-08","current":-1.397581,"twenty":-15.173104,"median":-6.727218,"eighty":-1.876918,"marketCap":1360381524},{"date":"2024-03-15","current":-1.57134,"twenty":-15.157554,"median":-6.598167,"eighty":-1.786278,"marketCap":1528161911},{"date":"2024-03-22","current":-1.554111,"twenty":-15.133384,"median":-6.571333,"eighty":-1.761258,"marketCap":1510023491},{"date":"2024-03-28","current":-1.411615,"twenty":-15.096291,"median":-6.502126,"eighty":-1.704775,"marketCap":1367183431},{"date":"2024-04-05","current":-2.311946,"twenty":-15.036248,"median":-6.432387,"eighty":-1.733087,"marketCap":1312768170},{"date":"2024-04-12","current":-2.23481,"twenty":-15.015695,"median":-6.325374,"eighty":-1.750718,"marketCap":1269689422},{"date":"2024-04-19","current":-2.220743,"twenty":-14.978343,"median":-6.232337,"eighty":-1.757168,"marketCap":1260620212},{"date":"2024-04-26","current":-2.487423,"twenty":-14.880573,"median":-6.21873,"eighty":-1.764247,"marketCap":1410262179},{"date":"2024-05-03","current":-2.681232,"twenty":-14.815623,"median":-6.213824,"eighty":-1.771741,"marketCap":1519092701},{"date":"2024-05-10","current":-2.694844,"twenty":-14.732215,"median":-6.194402,"eighty":-1.778188,"marketCap":1530429214},{"date":"2024-05-17","current":-3.00267,"twenty":-14.553789,"median":-6.183854,"eighty":-1.780643,"marketCap":1702744207},{"date":"2024-05-24","current":-3.217957,"twenty":-14.198245,"median":-6.124303,"eighty":-1.786278,"marketCap":1820660856},{"date":"2024-05-31","current":-2.054078,"twenty":-13.923474,"median":-5.974351,"eighty":-1.796836,"marketCap":1573168599},{"date":"2024-06-07","current":-1.9381,"twenty":-13.664785,"median":-5.653035,"eighty":-1.807103,"marketCap":1482503119},{"date":"2024-06-14","current":-1.91102,"twenty":-13.331508,"median":-5.238662,"eighty":-1.824362,"marketCap":1460449354},{"date":"2024-06-21","current":-1.927882,"twenty":-12.903839,"median":-5.053769,"eighty":-1.852029,"marketCap":1470251028},{"date":"2024-06-28","current":-1.713313,"twenty":-12.466177,"median":-4.63432,"eighty":-1.812627,"marketCap":1306072996},{"date":"2024-07-05","current":-1.498268,"twenty":-12.331204,"median":-4.126403,"eighty":-1.78188,"marketCap":1141894965},{"date":"2024-07-12","current":-1.451124,"twenty":-12.127912,"median":-3.217957,"eighty":-1.758268,"marketCap":1107589107},{"date":"2024-07-19","current":-1.287367,"twenty":-12.111765,"median":-3.012866,"eighty":-1.713313,"marketCap":982617770},{"date":"2024-07-26","current":-1.247418,"twenty":-12.007318,"median":-2.886721,"eighty":-1.666028,"marketCap":955663168},{"date":"2024-08-02","current":-1.395363,"twenty":-11.998731,"median":-2.789269,"eighty":-1.627624,"marketCap":1068382413},{"date":"2024-08-09","current":-1.278032,"twenty":-11.945022,"median":-2.694844,"eighty":-1.591621,"marketCap":985068188},{"date":"2024-08-16","current":-1.236222,"twenty":-11.935103,"median":-2.660283,"eighty":-1.57485,"marketCap":953212749},{"date":"2024-08-23","current":-0.81646,"twenty":-11.933477,"median":-2.608234,"eighty":-1.57134,"marketCap":632207942},{"date":"2024-08-30","current":-0.952471,"twenty":-11.81436,"median":-2.571987,"eighty":-1.551773,"marketCap":742476769},{"date":"2024-09-06","current":-1.447493,"twenty":-11.784199,"median":-2.555096,"eighty":-1.517315,"marketCap":715522166},{"date":"2024-09-13","current":-1.093439,"twenty":-11.638104,"median":-2.497929,"eighty":-1.486695,"marketCap":539092043},{"date":"2024-09-20","current":-1.067159,"twenty":-11.636282,"median":-2.450786,"eighty":-1.47795,"marketCap":529290370},{"date":"2024-09-27","current":-1.497859,"twenty":-11.627863,"median":-2.421257,"eighty":-1.472712,"marketCap":747377605},{"date":"2024-10-04","current":-1.814241,"twenty":-11.616631,"median":-2.394839,"eighty":-1.474321,"marketCap":901128718},{"date":"2024-10-10","current":-1.489673,"twenty":-11.533979,"median":-2.351569,"eighty":-1.475742,"marketCap":735125514},{"date":"2024-10-18","current":-1.272859,"twenty":-11.403336,"median":-2.329706,"eighty":-1.46491,"marketCap":624856686},{"date":"2024-10-25","current":-1.297899,"twenty":-11.356077,"median":-2.303878,"eighty":-1.451758,"marketCap":637108778},{"date":"2024-11-01","current":-1.147368,"twenty":-11.298787,"median":-2.278017,"eighty":-1.445363,"marketCap":563596227},{"date":"2024-11-08","current":-1.072416,"twenty":-11.256648,"median":-2.257268,"eighty":-1.422436,"marketCap":524389533},{"date":"2024-11-15","current":-1.088958,"twenty":-11.238973,"median":-2.230583,"eighty":-1.408191,"marketCap":526839951},{"date":"2024-11-22","current":-0.998262,"twenty":-11.204577,"median":-2.223731,"eighty":-1.39625,"marketCap":482732420},{"date":"2024-11-29","current":-0.851881,"twenty":-11.151287,"median":-2.209822,"eighty":-1.388142,"marketCap":411670287},{"date":"2024-12-06","current":-0.930133,"twenty":-11.118908,"median":-2.168961,"eighty":-1.377696,"marketCap":448426563},{"date":"2024-12-13","current":-1.85376,"twenty":-11.09452,"median":-2.147651,"eighty":-1.370745,"marketCap":891952290},{"date":"2024-12-20","current":-1.703433,"twenty":-11.080155,"median":-2.118695,"eighty":-1.37491,"marketCap":815989320},{"date":"2024-12-27","current":-1.556293,"twenty":-11.0629,"median":-2.091035,"eighty":-1.37609,"marketCap":744927187},{"date":"2025-01-03","current":-1.718431,"twenty":-11.019506,"median":-2.087656,"eighty":-1.379303,"marketCap":823340575},{"date":"2025-01-10","current":-1.781439,"twenty":-10.961868,"median":-2.066203,"eighty":-1.384151,"marketCap":850295177},{"date":"2025-01-17","current":-1.595334,"twenty":-10.900489,"median":-2.053915,"eighty":-1.385216,"marketCap":762080116},{"date":"2025-01-24","current":-1.468152,"twenty":-10.854506,"median":-2.050293,"eighty":-1.387406,"marketCap":705720493},{"date":"2025-01-28","current":-1.410439,"twenty":-10.839972,"median":-2.049728,"eighty":-1.388046,"marketCap":681216309},{"date":"2025-02-07","current":-1.530008,"twenty":-10.814975,"median":-2.037951,"eighty":-1.389076,"marketCap":735125514},{"date":"2025-02-14","current":-1.528559,"twenty":-10.795891,"median":-2.028723,"eighty":-1.391863,"marketCap":732675095},{"date":"2025-02-21","current":-1.571064,"twenty":-10.721381,"median":-2.004826,"eighty":-1.393217,"marketCap":757179279},{"date":"2025-02-28","current":-1.479337,"twenty":-10.697805,"median":-1.995766,"eighty":-1.395807,"marketCap":710621330},{"date":"2025-03-07","current":-1.453098,"twenty":-10.679729,"median":-1.991176,"eighty":-1.397955,"marketCap":700819656},{"date":"2025-03-14","current":-2.031566,"twenty":-10.667257,"median":-1.976655,"eighty":-1.400455,"marketCap":980167352},{"date":"2025-03-21","current":-1.925665,"twenty":-10.651254,"median":-1.983659,"eighty":-1.404731,"marketCap":928708566},{"date":"2025-03-28","current":-2.011029,"twenty":-10.632836,"median":-1.976655,"eighty":-1.405791,"marketCap":967915260},{"date":"2025-04-03","current":-4.849242,"twenty":-10.59211,"median":-1.990664,"eighty":-1.405908,"marketCap":948311913},{"date":"2025-04-11","current":-4.437868,"twenty":-10.510874,"median":-1.994435,"eighty":-1.410439,"marketCap":860096851},{"date":"2025-04-17","current":-4.507756,"twenty":-10.463016,"median":-2.001501,"eighty":-1.41138,"marketCap":874799361},{"date":"2025-04-25","current":-4.675473,"twenty":-10.425762,"median":-2.009202,"eighty":-1.413065,"marketCap":909105218},{"date":"2025-05-02","current":-4.200258,"twenty":-10.363363,"median":-2.018758,"eighty":-1.414101,"marketCap":818439738},{"date":"2025-05-09","current":-3.770261,"twenty":-10.249926,"median":-2.024588,"eighty":-1.414342,"marketCap":739809979},{"date":"2025-05-16","current":-4.284566,"twenty":-10.026861,"median":-2.036469,"eighty":-1.415387,"marketCap":847596864},{"date":"2025-05-23","current":-4.777983,"twenty":-9.852015,"median":-2.041673,"eighty":-1.419898,"marketCap":948034643},{"date":"2025-05-30","current":-5.138125,"twenty":-9.830582,"median":-2.050293,"eighty":-1.430778,"marketCap":1023975402},{"date":"2025-06-06","current":-5.247659,"twenty":-9.785152,"median":-2.053915,"eighty":-1.435028,"marketCap":1048472421},{"date":"2025-06-13","current":-5.208817,"twenty":-9.581686,"median":-2.066203,"eighty":-1.441179,"marketCap":1041123316},{"date":"2025-06-20","current":-5.059405,"twenty":-9.29601,"median":-2.087656,"eighty":-1.444904,"marketCap":1009277191},{"date":"2025-06-27","current":-4.910572,"twenty":-9.249536,"median":-2.094017,"eighty":-1.44689,"marketCap":982330469},{"date":"2025-07-04","current":-5.326679,"twenty":-9.249366,"median":-2.118695,"eighty":-1.447493,"marketCap":1065620335},{"date":"2025-07-11","current":-6.190082,"twenty":-9.138123,"median":-2.133974,"eighty":-1.447493,"marketCap":1237099469},{"date":"2025-07-18","current":-7.27445,"twenty":-9.003332,"median":-2.159659,"eighty":-1.451124,"marketCap":1452673238},{"date":"2025-07-25","current":-7.309206,"twenty":-8.887181,"median":-2.192911,"eighty":-1.452709,"marketCap":1464921748},{"date":"2025-08-01","current":-9.101071,"twenty":-9.003332,"median":-2.220996,"eighty":-1.453098,"marketCap":1812779420},{"date":"2025-08-08","current":-9.716302,"twenty":-9.138123,"median":-2.225619,"eighty":-1.456353,"marketCap":1940163920},{"date":"2025-08-15","current":-10.22234,"twenty":-9.332563,"median":-2.248216,"eighty":-1.456376,"marketCap":2038151997},{"date":"2025-08-22","current":-9.946369,"twenty":-9.716302,"median":-2.272725,"eighty":-1.457805,"marketCap":1976909449},{"date":"2025-08-29","current":-9.960443,"twenty":-9.747702,"median":-2.282688,"eighty":-1.461258,"marketCap":1989157959},{"date":"2025-09-05","current":-10.155894,"twenty":-9.804601,"median":-2.314722,"eighty":-1.464963,"marketCap":1869122564},{"date":"2025-09-12","current":-11.957904,"twenty":-9.898768,"median":-2.342593,"eighty":-1.466798,"marketCap":2204731728},{"date":"2025-09-19","current":-10.769756,"twenty":-10.069416,"median":-2.391298,"eighty":-1.468152,"marketCap":1984258555},{"date":"2025-09-26","current":-9.744656,"twenty":-10.155894,"median":-2.421257,"eighty":-1.470387,"marketCap":1790732103},{"date":"2025-10-03","current":-10.718868,"twenty":-10.323969,"median":-2.439051,"eighty":-1.472041,"marketCap":1974459747},{"date":"2025-10-10","current":-9.071752,"twenty":-10.325553,"median":-2.487423,"eighty":-1.472648,"marketCap":1668619305},{"date":"2025-10-17","current":-8.19764,"twenty":-10.305986,"median":-2.541442,"eighty":-1.473821,"marketCap":1506665078},{"date":"2025-10-24","current":-8.167968,"twenty":-10.251425,"median":-2.565892,"eighty":-1.47491,"marketCap":1501757375},{"date":"2025-10-31","current":-8.409006,"twenty":-10.195762,"median":-2.603679,"eighty":-1.475243,"marketCap":1548380561},{"date":"2025-11-07","current":-7.054111,"twenty":-10.133266,"median":-2.627346,"eighty":-1.475515,"marketCap":1298087665},{"date":"2025-11-14","current":-6.927803,"twenty":-10.095805,"median":-2.694844,"eighty":-1.475989,"marketCap":1278456850},{"date":"2025-11-21","current":-6.638358,"twenty":-10.082082,"median":-2.753741,"eighty":-1.477139,"marketCap":1224472108},{"date":"2025-11-28","current":-6.693864,"twenty":-10.05681,"median":-2.877596,"eighty":-1.478748,"marketCap":1239195219},{"date":"2025-12-05","current":-6.76177,"twenty":-10.021915,"median":-2.961448,"eighty":-1.481297,"marketCap":1253918331},{"date":"2025-12-12","current":-6.670038,"twenty":-9.982939,"median":-3.180097,"eighty":-1.484889,"marketCap":1239195219},{"date":"2025-12-19","current":-6.509408,"twenty":-9.954813,"median":-3.501028,"eighty":-1.486056,"marketCap":1212202848},{"date":"2025-12-24","current":-6.252747,"twenty":-9.946369,"median":-3.864695,"eighty":-1.486341,"marketCap":1168033513},{"date":"2026-01-02","current":-6.529179,"twenty":-9.908288,"median":-3.907859,"eighty":-1.486624,"marketCap":1224472108},{"date":"2026-01-09","current":-7.831217,"twenty":-9.865068,"median":-3.968033,"eighty":-1.486952,"marketCap":1472311152},{"date":"2026-01-16","current":-7.649734,"twenty":-9.838133,"median":-4.170946,"eighty":-1.488622,"marketCap":1442864928},{"date":"2026-01-23","current":-6.4981,"twenty":-9.821812,"median":-4.209184,"eighty":-1.489493,"marketCap":1224472108},{"date":"2026-01-30","current":-6.157418,"twenty":-9.807459,"median":-4.270574,"eighty":-1.48966,"marketCap":1165579662},{"date":"2026-02-06","current":-5.779794,"twenty":-9.786844,"median":-4.298075,"eighty":-1.490077,"marketCap":1096871808},{"date":"2026-02-13","current":-5.245388,"twenty":-9.778595,"median":-4.373938,"eighty":-1.496323,"marketCap":1001171583},{"date":"2026-02-20","current":-4.995457,"twenty":-9.774412,"median":-4.390862,"eighty":-1.497941,"marketCap":952094544},{"date":"2026-02-27","current":-5.374263,"twenty":-9.758735,"median":-4.464523,"eighty":-1.49875,"marketCap":1035525510},{"date":"2026-03-06","current":-4.878714,"twenty":-9.747093,"median":-4.501988,"eighty":-1.500679,"marketCap":932463729},{"date":"2026-03-13","current":-4.958586,"twenty":-9.740702,"median":-4.609457,"eighty":-1.50131,"marketCap":952094544},{"date":"2026-03-20","current":-5.272487,"twenty":-9.723168,"median":-4.649929,"eighty":-1.50404,"marketCap":1008533139}],"updateTime":1774051591919},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01244\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130840857","title":"3D Medicines (01244): Board Meeting Set for 31 March 2026 to Approve FY 2025 Audited Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1130840857","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130840857?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:23","pubTimestamp":1773922987,"startTime":"0","endTime":"0","summary":"3D Medicines Inc. (stock code: 01244) has scheduled a board meeting for 31 March 2026. According to the company’s announcement, the agenda will include: • Approval and publication of the audited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"gpt_icon":0},{"id":"2620240605","title":"3D Medicines sets board meeting to approve audited annual results and consider final dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2620240605","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620240605?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:15","pubTimestamp":1773922520,"startTime":"0","endTime":"0","summary":"A 3D Medicines board meeting is scheduled for March 31, 2026.The board is expected to consider the company’s audited annual results and a final dividend.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3D Medicines Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLrQgT1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1161"],"gpt_icon":0},{"id":"1107694644","title":"3D Medicines (01244) Announces February 2026 Monthly Return with No Change in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1107694644","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107694644?lang=en_us&edition=fundamental","pubTime":"2026-03-04 18:21","pubTimestamp":1772619685,"startTime":"0","endTime":"0","summary":"3D Medicines Inc. (Stock Code: 01244) published its monthly return for equity issuers, covering the period ended 28 February 2026. The company reported that its authorised share capital remained at...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"gpt_icon":0},{"id":"2610654580","title":"BRIEF-3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2610654580","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610654580?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:37","pubTimestamp":1770651438,"startTime":"0","endTime":"0","summary":"BRIEF-3D Medicines Inc Says Envafolimab Supplemental Application Accepted By NMPAFeb 9 (Reuters) - 3D Medicines Inc 1244.HK:ENVAFOLIMAB SUPPLEMENTAL APPLICATION FOR CONDITIONAL-TO-REGULAR APPROVAL TRANSITION ACCEPTED BY NMPAFurther company coverage: 1244.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z5175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1100972979","title":"3D MEDICINES Receives NMPA Acceptance for Full Approval Application of Envida®","url":"https://stock-news.laohu8.com/highlight/detail?id=1100972979","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100972979?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:06","pubTimestamp":1770649580,"startTime":"0","endTime":"0","summary":"3D MEDICINES (01244) announced that the supplemental application for Envida® (generic name: Envafolimab Injection) to convert its conditional approval to full approval for the domestically produced...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1175194129","title":"3D Medicines Inc. (Stock Code: 1244) Announces NMPA Acceptance for Envafolimab Conditional-to-Regular Approval Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1175194129","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175194129?lang=en_us&edition=fundamental","pubTime":"2026-02-09 23:02","pubTimestamp":1770649354,"startTime":"0","endTime":"0","summary":"3D Medicines Inc. (思路迪医药股份有限公司, Stock Code: 1244) announced that the National Medical Products Administration (NMPA) has officially accepted the supplemental application for 恩維達® (Envafolimab) to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"gpt_icon":0},{"id":"2610659792","title":"3D Medicines Inc - Envafolimab Supplemental Application for Conditional-to-Regular Approval Transition Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2610659792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610659792?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:54","pubTimestamp":1770648862,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z5175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2602541198","title":"BRIEF-3D Medicines Inc Says Zhang Jing Resigns As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2602541198","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602541198?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:35","pubTimestamp":1768232125,"startTime":"0","endTime":"0","summary":"BRIEF-3D Medicines Inc Says Zhang Jing Resigns As CFOJan 12 (Reuters) - 3D Medicines Inc 1244.HK:ZHANG JING RESIGNS AS CFOLU XIAOHAO APPOINTED AS CFOFurther company coverage: 1244.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD16V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1161"],"gpt_icon":0},{"id":"1145832516","title":"3D MEDICINES (01244) Appoints Lu Xiao Hao as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=1145832516","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145832516?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:06","pubTimestamp":1768226786,"startTime":"0","endTime":"0","summary":"3D MEDICINES (01244) announced that Ms. Zhang Jing has formally resigned from her position as the company's Chief Financial Officer; Mr. Lu Xiao Hao has been appointed as the new Chief Financial Officer, with the appointment taking effect immediately.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2602543718","title":"3D Medicines Inc. Appoints Lu Xiaohao as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543718","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543718?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:02","pubTimestamp":1768226548,"startTime":"0","endTime":"0","summary":"3D Medicines Inc. has announced that Ms. Zhang Jing has resigned as Chief Financial Officer and Mr. Lu Xiaohao has been appointed to the role, effective immediately.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3D Medicines Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL8HLlFs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2602543241","title":"3D Medicines Inc - Zhang Jing Resigns as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543241","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543241?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:02","pubTimestamp":1768226546,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD16V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2602372081","title":"BRIEF-3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=2602372081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602372081?lang=en_us&edition=fundamental","pubTime":"2026-01-09 23:15","pubTimestamp":1767971744,"startTime":"0","endTime":"0","summary":"BRIEF-3D Medicines Says New Drug Application For First-Line Treatment Of Biliary Tract Cancer Of Envafolimab AcceptedJan 9  - 3D Medicines Inc 1244.HK:NEW DRUG APPLICATION FOR FIRST-LINE TREATMENT OF BILIARY TRACT CANCER OF ENVAFOLIMAB ACCEPTED BY NMPAFurther company coverage: 1244.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA04X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1184618286","title":"3D MEDICINES (01244): New Drug Application for ENVAFOLIMAB as First-Line Treatment for Biliary Tract Cancer Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1184618286","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184618286?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:08","pubTimestamp":1767967697,"startTime":"0","endTime":"0","summary":"3D MEDICINES (01244) announced that the National Medical Products Administration (NMPA) has formally accepted the company's New Drug Application (NDA) for its commercial product ENVAFOLIMAB® (generic...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2602937158","title":"3D Medicines Inc - New Drug Application for First-Line Treatment of Biliary Tract Cancer of Envafolimab Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2602937158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602937158?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:00","pubTimestamp":1767967254,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA04X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2593434378","title":"BRIEF-3D Medicines Says Envafoimab Granted Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2593434378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593434378?lang=en_us&edition=fundamental","pubTime":"2025-12-23 01:27","pubTimestamp":1766424460,"startTime":"0","endTime":"0","summary":"BRIEF-3D Medicines Says Envafoimab Granted Orphan Drug DesignationDec 22 (Reuters) - 3D Medicines Inc 1244.HK:ENVAFOIMAB GRANTED ORPHAN DRUG DESIGNATIONDESIGNATION FOR TREATMENT OF GASTRIC CANCER AND ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS09K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1167889245","title":"3D MEDICINES (01244): ENVAFOLIMAB® Granted Orphan Drug Designation for Gastric and Gastroesophageal Junction Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1167889245","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167889245?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:16","pubTimestamp":1766412983,"startTime":"0","endTime":"0","summary":"3D MEDICINES (01244) announced that its commercialized product ENVAFOLIMAB® (generic name: Envafolimab Injection, R&D code: KN035) has officially received orphan drug designation for gastric cancer...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2593433397","title":"3D Medicines Inc - Envafoimab Granted Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2593433397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593433397?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:10","pubTimestamp":1766412602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS09K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2593433390","title":"3D Medicines Inc - Designation for Treatment of Gastric Cancer and - Gastro-Esophageal Junction Cancer Indications by China Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2593433390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593433390?lang=en_us&edition=fundamental","pubTime":"2025-12-22 22:10","pubTimestamp":1766412602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS09K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1186879759","title":"3D Medicines Inc. (01244) Publishes November 2025 Monthly Return on Movements in Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1186879759","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186879759?lang=en_us&edition=fundamental","pubTime":"2025-12-04 12:04","pubTimestamp":1764821097,"startTime":"0","endTime":"0","summary":"3D Medicines Inc. discloses that the authorized share capital remained at 500 million ordinary shares, each with a par value of HKD 0.001, reflecting a total of HKD 500,000 as of November 30, 2025....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"gpt_icon":0},{"id":"2584758993","title":"Does 3D Medicines (HKG:1244) Have A Healthy Balance Sheet?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584758993","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584758993?lang=en_us&edition=fundamental","pubTime":"2025-11-19 06:55","pubTimestamp":1763506554,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1244/3d-medicines-shares/news/does-3d-medicines-hkg1244-have-a-healthy-balance-sheet","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1244/3d-medicines-shares/news/does-3d-medicines-hkg1244-have-a-healthy-balance-sheet","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","EBIT","01244"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}